Vertex Pharmaceuticals (NASDAQ: VRTX)
Vertex Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Vertex Pharmaceuticals Company Info
Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis.
News & Analysis
The Best CRISPR Companies to Invest In
These CRISPR stocks could be big winners for patient investors.
Why This Biotech Company Could Be a Growth Stock Powerhouse
Recent developments aren't as devastating to the company's prospects as some might think.
Investing in the Best Healthcare Stocks
This Magnificent S&P 500 Dividend Stock Is Down 18% -- Time to Buy?
It's been an unusually bad year for this drugmaker, but it's essential to look beyond that.
What's Wrong With Vertex Pharmaceuticals Stock?
Shares of the pharma company are down 17% in the past 12 months.
Is This Beaten-Down Stock a Buy on the Dip?
It's the second time this year the stock has slumped significantly in one day, and it might represent another attractive entry point.
2 Growth Stocks That Are No-Brainer Buys Right Now
These stocks have outperformed broader equities over the past decade and still have room to run.
7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip
There's more good news than bad news for this big biotech stock.
Valuation
Podcast Episodes
Alleged Industrial Espionage Makes an Interesting Story
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
3 Biotech Companies Analyzed
We examine three biotech companies' past performances and future outlooks.
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Earnings Transcripts
Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call Transcript
VRTX earnings call for the period ending December 31, 2024.
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript
VRTX earnings call for the period ending September 30, 2024.
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
VRTX earnings call for the period ending June 30, 2024.
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
VRTX earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.